title: Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation.
abstract: Alzheimer disease (AD) and stroke are two leading causes of age-associated dementia. Increasing evidence points to vascular damage as an early contributor to the development of AD and AD-like pathology. In this review, we discuss the role of G protein-coupled receptor kinase 2 (GRK2) as it relates to individuals affected by AD and how the cardiovasculature plays a role in AD pathogenesis. The possible involvement of GRKs in AD pathogenesis is an interesting notion, which may help bridge the gap in our understanding of the heartbrain connection in relation to neurovisceral damage and vascular complications in AD, since kinases of this family are known to regulate numerous receptor functions both in the brain, myocardium, and elsewhere. The aim of this review is to discuss our findings of overexpression of GRK2 in the context of the early pathogenesis of AD, because increased levels of GRK2 immunoreactivity were found in vulnerable neurons of AD patients as well as in a two-vessel occlusion (2-VO) mammalian model of ischaemia. Also, we consider the consequences for this overexpression as a loss of G-protein coupled receptor (GPCR) regulation, as well as suggest a potential role for GPCRs and GRKs in a unifying theory of AD pathogenesis, particularly in the context of cerebrovascular disease. We synthesize this newer information and attempt to put it into context with GRKs as regulators of diverse physiological cellular functions that could be appropriate targets for future pharmacological intervention.
authors.affiliation: Department of Pathology, Case Western Reserve University, Cleveland, OH, USA.
authors.forename: Mark E
authors.initials: ME
authors.lastname: Obrenovich
authors.forename: Ludis A
authors.initials: LA
authors.lastname: Morales
authors.forename: Celia J
authors.initials: CJ
authors.lastname: Cobb
authors.forename: Justin C
authors.initials: JC
authors.lastname: Shenk
authors.forename: Gina M
authors.initials: GM
authors.lastname: Méndez
authors.forename: Kathryn
authors.initials: K
authors.lastname: Fischbach
authors.forename: Mark A
authors.initials: MA
authors.lastname: Smith
authors.forename: Eldar K
authors.initials: EK
authors.lastname: Qasimov
authors.forename: George
authors.initials: G
authors.lastname: Perry
authors.forename: Gjumrakch
authors.initials: G
authors.lastname: Aliev
mesh_terms: D000544:Alzheimer Disease / Q000201:enzymology* / Q000209:etiology / Q000473:pathology; D000818:Animals; D002561:Cerebrovascular Disorders / Q000150:complications / Q000201:enzymology* / Q000473:pathology; D054769:G-Protein-Coupled Receptor Kinase 2 / Q000378:metabolism*; D006801:Humans; D009474:Neurons / Q000201:enzymology* / Q000473:pathology; D020521:Stroke / Q000150:complications / Q000201:enzymology / Q000473:pathology
chemical_list: D054769:G-Protein-Coupled Receptor Kinase 2